| Serial Number | 79156518 |
| Word Mark | SRYSATA |
| Filing Date | Thursday, October 2, 2014 |
| Status | 404 - IR CANCELLED - US REGISTRATION CANCELLED |
| Status Date | Friday, February 4, 2022 |
| Registration Number | 4733792 |
| Registration Date | Tuesday, May 12, 2015 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 24, 2015 |
| Goods and Services | Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system, pharmaceutical preparations for the prevention and treatment of inflammatory disorders, pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders, pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | H - NOT AVAILABLE |
| Class Status Date | Thursday, May 17, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | NOVARTIS AG |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | CH |
| Party Name | NOVARTIS AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | CH |
| Party Name | NOVARTIS AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | CH |
| Event Date | Event Description |
| Monday, May 23, 2022 | NOTIFICATION PROCESSED BY IB |
| Sunday, February 20, 2022 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
| Sunday, February 20, 2022 | DEATH OF INTERNATIONAL REGISTRATION |
| Friday, March 1, 2019 | NOTIFICATION PROCESSED BY IB |
| Friday, November 2, 2018 | NOTIFICATION PROCESSED BY IB |
| Friday, June 1, 2018 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
| Friday, June 1, 2018 | DEATH OF INTERNATIONAL REGISTRATION |
| Friday, August 7, 2015 | NOTIFICATION PROCESSED BY IB |
| Thursday, July 23, 2015 | FINAL DISPOSITION NOTICE SENT TO IB |
| Thursday, July 23, 2015 | FINAL DISPOSITION PROCESSED |
| Thursday, June 11, 2015 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB |
| Tuesday, May 12, 2015 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, February 24, 2015 | PUBLISHED FOR OPPOSITION |
| Friday, February 20, 2015 | NOTIFICATION PROCESSED BY IB |
| Wednesday, February 4, 2015 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, February 4, 2015 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, February 4, 2015 | NOTICE OF PUBLICATION |
| Thursday, January 15, 2015 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, January 14, 2015 | ASSIGNED TO EXAMINER |
| Saturday, December 20, 2014 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, December 16, 2014 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Saturday, December 13, 2014 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Thursday, December 11, 2014 | SN ASSIGNED FOR SECT 66A APPL FROM IB |